Key result
Concurrent elevation of Lp(a), remnant cholesterol, and hsCRP is linked to ~183% higher MI risk.
Why the study?
Do elevated levels of lipoprotein(a), remnant cholesterol, and high-sensitivity C-reactive protein independently and cumulatively predict first myocardial infarction in a primary prevention population?
Cohort (n=306,183)
Do elevated levels of lipoprotein(a), remnant cholesterol, and high-sensitivity C-reactive protein independently and cumulatively predict first myocardial infarction in a primary prevention population?
Answers are grounded in this paper and cite their sources.
Elevated levels of lipoprotein(a), remnant cholesterol, and high-sensitivity C-reactive protein provide independent and cumulative predictive value for first myocardial infarction in primary prevention, suggesting utility in combined testing.
BACKGROUND: The predictive value of lipoprotein(a) (Lp[a]), high-sensitivity C-reactive protein (hsCRP), and remnant cholesterol (RC) beyond low-density lipoprotein cholesterol (LDL-C) varies across cardiovascular disease (CVD) outcomes. This analysis evaluates the extent to which concentrations of these non-LDL-C biomarkers improve MI-specific risk prediction in a primary prevention population. METHODS: We analyzed 306,183 UK Biobank participants free of cardiovascular disease at baseline with available Lp(a), RC, and hsCRP measurements. RC was calculated as total cholesterol minus LDL-C minus high-density lipoprotein cholesterol (HDLC). Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox regression across biomarker quintiles and cumulative biomarker burden. The primary endpoint was first MI. RESULTS: Over 15 years of follow-up, 10,824 MI events occurred. In fully adjusted models comparing quintile 5 with quintile 1, HRs (95% CI) were 1.09 (1.08-1.11) for Lp(a), 1.14 (1.13-1.16) for RC, and 1.08 (1.06-1.10) for hsCRP. Per-SD increases were associated with higher MI risk for RC 1.22 (1.20-1.25), Lp(a) 1.16 (1.13-1.18), and hsCRP 1.13 (1.10-1.15). The risk of MI increased stepwise with cumulative biomarker burden; compared with individuals with no biomarker in the top quintile, HRs (95% CI) were 1.45 (1.39-1.51), 2.14 (2.02-2.26), and 2.83 (2.48-3.24) for those with one, two, or all three elevated biomarkers, respectively. CONCLUSIONS: Lp(a), RC, and hsCRP each provide independent and complementary information for MI risk. Their combined elevation identifies individuals at higher MI risk, suggesting selective testing of all three biomarkers in primary prevention.
No takes yet. Share an insight, caveat, or question.
Kazibwe et al. (2026) conducted a cohort in Cardiovascular disease primary prevention (n=306,183). Elevated lipoprotein(a), remnant cholesterol, and high-sensitivity C-reactive protein vs. No biomarker in the top quintile was evaluated on first MI (HR 2.83, 95% CI 2.48-3.24). Having all three biomarkers (Lp[a], remnant cholesterol, and hsCRP) elevated in the top quintile was associated with an increased risk of first myocardial infarction.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: